Showing results (161-170 of 203) with videos related to

Sort By:
Pageof 21
British Journal of Cancer|May 22, 2008
Pegylated liposomal doxorubicin and gemcitabine in the front-line treatment of recurrent/metastatic breast cancer: a multicentre phase II studyV Adamo, V Lorusso, R Rossello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 7, 2011
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trialL Gladieff, A Ferrero, G De Rauglaudre, et al.
ESMO Open|February 18, 2021
Social distress among medical oncologists and other healthcare professionals during the first wave of COVID-19 pandemic in ItalyR Berardi, M Torniai, M S Cona, et al.
Current Cancer Drug Targets|April 3, 2012
High CXCR4 expression correlates with sunitinib poor response in metastatic renal cancerC D' Alterio, L Portella, A Ottaiano, et al.
Cancer Chemotherapy and Pharmacology|May 19, 2010
Phase I dose-escalation study of brostallicin, a minor groove binder, in combination with cisplatin in patients with advanced solid tumorsF Caponigro, D Lorusso, G Fornari, et al.
ESMO Open|July 18, 2022
Combining PARP inhibition and immune checkpoint blockade in ovarian cancer patients: a new perspective on the horizon?L Musacchio, C M Cicala, F Camarda, et al.
British Journal of Cancer|May 31, 2012
Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patientsD Lorusso, G Scambia, G Amadio, et al.
European Review for Medical and Pharmacological Sciences|July 30, 2013
Intravesical chemo-immunotherapy in non muscle invasive bladder cancerD Leopardo, S C Cecere, M Di Napoli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2019
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease†N Colombo, C Sessa, A du Bois, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervixS Pignata, G Silvestro, E Ferrari, et al.
Pageof 21